Stay updated on Fulvestrant & Pyrotinib in HR+/HER2+ Clinical Trial
Sign up to get notified when there's something new on the Fulvestrant & Pyrotinib in HR+/HER2+ Clinical Trial page.

Latest updates to the Fulvestrant & Pyrotinib in HR+/HER2+ Clinical Trial page
- Check4 days agoChange DetectedThe page’s footer/version indicator has been updated from Revision v3.5.2 to v3.5.3, reflecting a maintenance or release update to how the site is presented rather than any change to the study content.SummaryDifference0.1%

- Check11 days agoChange DetectedRevision: v3.5.2 has been added; Revision: v3.5.0 has been removed.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check41 days agoChange Detected- Revision history updated: added v3.5.0 and removed v3.4.3 entry.SummaryDifference0.1%

- Check48 days agoChange DetectedA new revision v3.4.3 was added and the previous revision v3.4.2 was deleted from the record history.SummaryDifference0.1%

- Check76 days agoChange DetectedA new revision entry v3.4.2 was added to the record history; the government funding notice and the v3.4.1 entry were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1.0%

- Check84 days agoChange DetectedA site-wide notice about a lapse in government funding was added, and the revision version was updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1.0%

Stay in the know with updates to Fulvestrant & Pyrotinib in HR+/HER2+ Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fulvestrant & Pyrotinib in HR+/HER2+ Clinical Trial page.